BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2019
View Archived Issues
Corona-mediated brain targeting using short peptides for association of exchangeable apolipoproteins
Read More
Claudin-5 is a key mediator of retinal pigment epithelium pathology regulated by the circadian clock
Read More
Palbociclib prevents chemo hair loss
Read More
Inflammation stress induces red blood cell formation
Read More
Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction
Read More
Enrollment ongoing in phase I study of EBV TCR-T cell therapy
Read More
Otonomy announces initiation of phase I/II study of OTO-413
Read More
Preliminary data announced from ongoing phase II study of fosmanogepix in candidemia
Read More
Treatment with luseogliflozin reverses cognitive impairments in elderly diabetes
Read More
Preliminary first-in-human data for ATA-188 support continuation of study
Read More
AMG-510 shows favorable safety profile, early promising antitumor activity in patients with NSCLC
Read More
IFN-alpha kinoid shows promise as a vaccine against type 1 diabetes in a NOD murine model
Read More
Gulp and scarf: senescent breast cancer cells eat their neighbors
Read More
Artax Biopharma presents new immunomodulators
Read More
Gilead Sciences divulges new antivirals for HBV infection
Read More
Ferro Therapeutics identifies PHGPx inhibitors
Read More
Samumed identifies new DYRK1A and/or GSK-3beta and IL-6 production inhibitors
Read More
Vitamin C-coupled compounds for cancer described in Gudui Biopharma Technology patent
Read More
FDA approves Erleada for metastatic castration-sensitive prostate cancer
Read More
Novel oxyntomodulin analogue OXM-001 reduces body weight and improves glucose tolerance
Read More
Keytruda plus Lenvima gains FDA approval for advanced endometrial carcinoma
Read More
Saniona reports phase IIa data analysis on Tesomet in adolescents with Prader-Willi syndrome
Read More
FDA clears IND for Ceraxa in AML
Read More
Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy
Read More
Durect completes phase IIa trial of DUR-928 in alcoholic hepatitis
Read More
Ra's zilucoplan selected for evaluation in ALS platform trial
Read More